Skip to content
Search AI Powered

Latest Stories

Continuing its self-care push, Maxwellia reveals plans to switch more products from POM to P

Maxwellia has revealed its plans to switch some of its medicines in the self-care category from prescription-only-medicine (POM) to a pharmacy (P) medicine.

After authorising the switch of Maxwellia's two brands of desogestrel contraceptive pills, Lovima and Hana, MHRA has opened a public consultation on reclassification of Aquiette (overactive bladder treatment) 2.5mg tablets manufactured by the company to be made available from pharmacies.


“Maxwellia is currently looking at a number of medicines which treat a range of conditions in major public health categories that can be ‘switched’ from needing a prescription to being conveniently bought at a local high street or supermarket pharmacy. With its foot firmly on the accelerator it has other applications under assessment with the MHRA, including women’s health products,” the company stated in a recent statement.

"Push to convert more prescription medicines to pharmacy medicines will firmly position pharmacists at heart of nation’s public health, helping futureproof NHS," the medicine said.

The Alderley Park, Cheshire-based company said that the switch could help ease unnecessary pressure on GPs, who are currently gatekeepers to a range of medicines that could easily be provided by a pharmacist with a short pharmacy consultation.

Maxwellia CEO, Anna Maxwell, said: “This pandemic has had a significant impact on people’s behaviour and attitudes to self-care. We are seeing signs that people are starting to pay closer attention to their health and taking active steps to make daily changes to take better care of their own health. A huge part of enabling this change will be to allow easier access to medicines that help people to better manage their own health more easily and conveniently.

“Britain’s pharmacies have become the ‘front door’ of the NHS over the past couple of years with pharmacists now the most accessible healthcare professional in the UK. I’ve always been passionate about the role of pharmacists, these are highly trained clinical experts helping patients and the public by assessing conditions and making decisions about which medicines or treatments would be most suitable, they dispense prescriptions and provide health checks and consultations.

“As a pharmacist myself, I know how important we are in helping people to self-care and see that pharmacists will play an increasingly important role in the local community as medical advisors. It’s vital more medicines are reclassified, from prescription-only to pharmacy status, enabling people to access them following a short consultation with a pharmacist.”

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less